Regencell Bioscience Holdings Limited (RGC) delivered a return of -81.04% over the past year. Since RGC does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in Regencell Bioscience Holdings Limited one year ago would be worth $1,896 today, representing a loss of $8,104.

Regencell Bioscience Holdings Limited (RGC) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For RGC, the total return equals the price-only return.

No, Regencell Bioscience Holdings Limited (RGC) underperformed the S&P 500 by 106.03 percentage points over the past year. RGC delivered a total return of -81.04%, compared to the S&P 500's 24.99%. This means a passive S&P 500 index fund outperformed RGC by 106.03pp during this period.

Regencell Bioscience Holdings Limited (RGC) experienced a maximum drawdown of -77.29% over the past year, declining from its peak on 2025-06-18 to its trough on 2025-07-02. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Here are Regencell Bioscience Holdings Limited (RGC)'s long-term returns with dividends reinvested. Over 10 years, the total return is 4804.1% (47.6% CAGR) — $10,000 would have grown to $490,409. Over 20 years: 6968.4% total return (23.7% CAGR) — $10,000 → $706,838. Over 30 years: 6968.4% total return (15.3% CAGR) — $10,000 → $706,840. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Regencell Bioscience Holdings Limited's best calendar year was 2025 with a total return of 16461.5%. Its worst year was 2023 with a total return of -62.4%. This range shows the volatility investors should expect — the difference between the best and worst year is 16523.9 percentage points.